Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth.
Zagato E
Nat Microbiol. 2020 Jan 27;5(3):511-524. doi: 10.1038/s41564-019-0649-5
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices.
Caldara M
Clin Microbiol Rev. 2022 Jan 19;35(2):e0022120. doi: 10.1128/cmr.00221-20
Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications.
Elia L, Quintavalle M
Front Cardiovasc Med. 2017 Apr 27;4:26. doi: 10.3389/fcvm.2017.00026
Epigenetics and vascular diseases.
Stratton MS, Farina FM, Elia L
J Mol Cell Cardiol. 2019 Jun 15;133:148-163. doi: 10.1016/j.yjmcc.2019.06.010
Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication.
Hudspeth K
Blood. 2012 Mar 8;119(17):4013-6. doi: 10.1182/blood-2011-11-390153
Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
Gagliano N
World J Gastroenterol. 22(18):4466-83. doi: 10.3748/wjg.v22.i18.4466
Evolving notions on immune response in colorectal cancer and their implications for biomarker development.
Grizzi F
Inflamm Res. 2018 Jan 10;67(5):375-389. doi: 10.1007/s00011-017-1128-1
ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma.
Savino B
Cancer Immunol Res. 2014 Apr 2;2(7):679-89. doi: 10.1158/2326-6066.CIR-13-0202
Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin.
Bello E
Br J Cancer. 2019 Aug 14;121(6):464-473. doi: 10.1038/s41416-019-0550-2
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment.
Allavena P
Front Oncol. 2022 Mar 1;12:851790. doi: 10.3389/fonc.2022.851790